MYP_148667
RC-101
Antimicrobial
Antimicrobial
▸
Antibacterial
Antiviral
▸
Anti-Herpesvirus
▸
Antiviral
▸
Antiviral
▸
Anti-HIV
▸
Antiviral
▸
Antiviral mechanism
▸
Antiviral
▸
Antiviral mechanism
▸
Viral replication inhibition
▸
Standard
18 amino acids
C74H136N28O19S6
Standard
GICRCICGKGICRCICGR
1914.44 Da
8.98
3.70
3.41
0.2055
0.78
0.57
0.01
-9.42
86.67
0.0000
0.00
375.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
769.74
-9.15
35.0
29.0
65.0
127.0
0.0
17.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0007028
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-16, 5-14, 7-12
Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.
Bio-Activity Profile
Anti-HIV-1
Entry inhibition
HIV-1 98TZ017 | JC53-BL cells
4.9 μg/mL
IC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0015272
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-16, 5-14, 7-12
Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.
Bio-Activity Profile
Anti-HIV-1
Entry inhibition
HIV-1 5157-35097 | JC53-BL cells
4 μg/mL
IC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0035452
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-16, 5-14, 7-12
Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.
Bio-Activity Profile
Anti-HIV-1
Entry inhibition
HIV-1 93US151 | JC53-BL cells
0.5 μg/mL
IC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0050409
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-16, 5-14, 7-12
Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.
Bio-Activity Profile
Anti-HIV-1
Entry inhibition
HIV-1 193317 | JC53-BL cells
2.7 μg/mL
IC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0073629
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial
Showing 5 records on this page · Page 1 of 6